The Oncology Institute, Inc. (TOI) Stock Analysis & Investment Frameworks
The Oncology Institute, Inc. (TOI) stock analysis on Invetso. Review The Oncology Institute, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
The Oncology Institute, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Care Facilities
- Country: US
The Oncology Institute, Inc. Key Financial Metrics
- Market Cap: $512.91M
- Revenue: $502.73M
- ROE: 209.81%
- ROIC: -28.82%
- Dividend Yield: N/A
About The Oncology Institute, Inc.
The Oncology Institute (TOI) is a specialized healthcare provider delivering a full range of medical oncology services throughout the United States. Its comprehensive offerings include direct physician care, integrated on-site infusion and medication dispensing facilities, and advanced clinical trial management. The institute also provides radiation therapy, specialized outpatient programs for stem cell transplants and transfusions, and robust patient support services. Furthermore, TOI is actively involved in operating palliative care initiatives and overseeing clinical trials. These services are specifically designed to meet the needs of adult and senior cancer patients. The company maintains a significant operational footprint with 67 clinic locations. The Oncology Institute was established in 2007 and is headquartered in Cerritos, California.